title: Overview: from heparin to low molecular weight heparin: beyond anticoagulation.
authors.affiliation: DuPont Pharmaceuticals Co, Experimental Station, Wilmington, DE 19880-0400, USA. shaker.a.mousa@dupontpharma.com
authors.forename: S A
authors.initials: SA
authors.lastname: Mousa
authors.forename: J
authors.initials: J
authors.lastname: Fareed
mesh_terms: D000818:Animals; D000925:Anticoagulants / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D006493:Heparin / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D019763:Heparin Lyase / Q000378:metabolism; D006495:Heparin, Low-Molecular-Weight / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D006801:Humans
chemical_list: D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D006493:Heparin; D019763:Heparin Lyase